Dexmedetomidine-ketamine and Dexmedetomidine-Midazolam-Fentanyl combinations for sedation in chemoport insertion procedure

Dexmedetomidine-ketamine and Dexmedetomidine-Midazolam-Fentanyl combinations for sedation in chemoport insertion procedure: a randomized prospective study

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

CRIS

Registry ID

KCT0000951

Enrollment

Registered

2013-12-12

Start date

2013-11-15

Completion date

Unknown

Last updated

2019-03-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Drug : Dexmedetomidine and ketamine are used in Group I and Dexmedetomidine-Midazolam-Fentanyl combinations are used in Group II for sedation in chemoport insertion procedure. 1)Dexmedetomidine (Prec

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1) 18-65 age 2) ASA (American society of anesthesiologists)class I-II 3) Patients undergoing chemoport insertion procedure in the Ewha womans university mokdong hospital

Exclusion criteria

Exclusion criteria: 1) Contraindication to dexmedetomidine, Ketamine, Midazolam, Fentanyl 2) underlying psychologic disorder 3) > ASA class 3 4) decreased renal, hepatic function 5) respiratory disease, sleep apnea, airway obstructive disease.

Design outcomes

Primary

Measure	Time frame
recovery time : time to spontaneous eye opening, length of stay in RR, time for achieving Aldrete score : 9	—

Secondary

Measure	Time frame
satisfactory score of surgeon, anesthesiologist and patient;Respiratory variables : SpO2, EtCO2(nasal), apnea, dyspnea, airway spasm ;sedation score, analgesic status;Hemodynamic variables : BP(s/d/m), HR	—

Countries

Korea, Republic of

Contacts

Public ContactJin Hye Han

Ewha Womans University Medical Center

Outcome results